🇺🇸 FDA
Pipeline program

Afinitor 2.5 mg tablets, Afinitor 10 mg tablets

CSET 2014/2126

Phase 3 small_molecule active

Quick answer

Afinitor 2.5 mg tablets, Afinitor 10 mg tablets for Children, adolescents and adults with newly diagnosed diffuse intrinsic pontine glioma and other diffuse midline gliomas H3K28M mutant or EZHIP positive is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Children, adolescents and adults with newly diagnosed diffuse intrinsic pontine glioma and other diffuse midline gliomas H3K28M mutant or EZHIP positive
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials